Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma—A report from the German Cooperative Pediatric Liver Tumor Study HB-89
- 1 June 1995
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 30 (6) , 845-852
- https://doi.org/10.1016/0022-3468(95)90762-9
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chemotherapy can convert unresectable hepatoblastomaJournal of Pediatric Surgery, 1992
- Hepatoblastoma: The Prognostic Significance of Histologic TypePediatric Pathology, 1992
- Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.Journal of Clinical Oncology, 1991
- Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A siop pilot studyMedical and Pediatric Oncology, 1991
- The clinical features and prognosis of hepatoblastoma: Follow-up studies done on pediatric tumors enrolled in the Japanese pediatric tumor registry between 1971 and 1980. Part ISurgery Today, 1990
- Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinomaCancer, 1989
- Hepatoblastoma and hepatocarcinoma in children: Analysis of a series of 29 casesJournal of Pediatric Surgery, 1986
- Adriamycin and cisplatin for hepatoblastomaCancer, 1985
- Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatomaCancer, 1982
- Hepatoblastoma and hepatocarcinoma in infancy and childhood.Report of 47 casesCancer, 1967